Literature DB >> 32785624

The Use of Sacubitril/Valsartan for Hospitalized Heart Failure-Why Do We Care About Cost and Value?

Clyde W Yancy1,2, Adrian F Hernandez3,4, Robert O Bonow1,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32785624     DOI： 10.1001/jamacardio.2020.3108

Source DB:  PubMed          Journal:  JAMA Cardiol            Impact factor:   14.676


× No keyword cloud information.
  1 in total

1.  Cost-Utility Analysis of Sacubitril-Valsartan Compared with Enalapril Treatment in Patients with Acute Decompensated Heart Failure in Thailand.

Authors:  Rungroj Krittayaphong; Unchalee Permsuwan
Journal:  Clin Drug Investig       Date:  2021-09-17       Impact factor: 3.580
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.